The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: #JPM23, the future of Alzheimer’s, & rising Covid variants
The Aduhelm Files Damian Garde and Rachel Cohrs In wake of House investigation, 5 burning questions for FDA, Biogen, and Alzheimer’s treatments
The Aduhelm Files Rachel Cohrs, Adam Feuerstein and Damian Garde FDA, Biogen, and an Alzheimer’s drug approval: 8 key takeaways from congressional investigation
The Aduhelm Files Damian Garde and Adam Feuerstein Seeking maximum profits, Biogen set an ‘unjustifiably high price’ for Alzheimer’s treatment, investigation finds
Biotech Jason Mast Still hoping for looser FDA rules, Regeneron says it will test durable antibody for Covid
Biotech Jonathan Wosen FDA’s Califf says congressional report on Aduhelm controversy contained ‘no surprises’
First Opinion Enes Hosgor and Oguz Akin Four types of bias in medical AI are running under the FDA’s radar
Health Eric Boodman ‘It’s taken longer than I thought’: A former FDA commissioner on the loosened restrictions on abortion pills
The Aduhelm Files Rachel Cohrs ‘Rife with irregularities’: Congressional investigation reveals FDA’s approval of Aduhelm marked by secret discussions, breaches of protocol
Pharmalot Ed Silverman McDonald’s adds targets for limiting antibiotic use in beef to its menu, but doesn’t say when
Biotech Jason Mast Drugmakers ask regulators to change standards on new Covid antibody drugs for most vulnerable
Pharmalot Ed Silverman Amid fears of superbugs, sales of antibiotics used in food-producing livestock barely declined last year
First Opinion Scott Gottlieb and Mark B. McClellan Congress needs to update FDA’s ability to regulate diagnostic tests, cosmetics
Biotech Kate Sheridan and Allison DeAngelis FDA approves first fecal microbiome drug, setting stage for others
Health Lev Facher Resistance to FDA’s opioid-disposal plan raises concerns about CADCA, a powerful advocacy group
Biotech Adam Feuerstein GSK to withdraw blood cancer drug from U.S. market following confirmatory study setback
Pharmalot Ed Silverman Pharmalittle: Type 1 diabetes drug is priced at $194,000; abortion opponents sue FDA over abortion pill approval
Health Nicholas Florko To gin up opposition to the proposed menthol ban, tobacco companies are turning to gas station ads
Health Nicholas Florko FDA formally warns companies behind Family Guy vapes, other illegal products marketed at kids
Politics Nicholas Florko The FDA has banned certain vapes and medicines. We still bought these 13 products in its backyard
Biotech Adam Feuerstein Immunogen wins FDA approval for targeted medicine to treat advanced ovarian cancer
Health Usha Lee McFarling Pulse oximeters and their inaccuracies will get FDA scrutiny. What took so long?
Pharmalot Jason Mast Pharmalittle: FDA advisers vote down pediatric brain cancer drug; AbbVie drops out of psoriasis partnership